Literature DB >> 21174070

[Diagnosis and treatment of neuromyelitis optica. Consensus recommendations of the Neuromyelitis Optica Study Group].

C Trebst1, A Berthele, S Jarius, T Kümpfel, S Schippling, B Wildemann, C Wilke.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 21174070     DOI： 10.1007/s00115-010-3192-4

Source DB:  PubMed          Journal:  Nervenarzt        ISSN： 0028-2804            Impact factor:   1.214


× No keyword cloud information.
  84 in total

1.  NMO-IgG in the diagnosis of neuromyelitis optica.

Authors:  S Jarius; D Franciotta; R Bergamaschi; H Wright; E Littleton; J Palace; R Hohlfeld; A Vincent
Journal:  Neurology       Date:  2007-02-07       Impact factor: 9.910

2.  Establishment of a new sensitive assay for anti-human aquaporin-4 antibody in neuromyelitis optica.

Authors:  Toshiyuki Takahashi; Kazuo Fujihara; Ichiro Nakashima; Tatsuro Misu; Isabelle Miyazawa; Masashi Nakamura; Shohei Watanabe; Naoto Ishii; Yasuto Itoyama
Journal:  Tohoku J Exp Med       Date:  2006-12       Impact factor: 1.848

3.  Neuromyelitis optica IgG predicts relapse after longitudinally extensive transverse myelitis.

Authors:  Brian G Weinshenker; Dean M Wingerchuk; Sandra Vukusic; Linda Linbo; Sean J Pittock; Claudia F Lucchinetti; Vanda A Lennon
Journal:  Ann Neurol       Date:  2006-03       Impact factor: 10.422

4.  Therapeutic efficacy of plasma exchange in NMO-IgG-positive patients with neuromyelitis optica.

Authors:  S Watanabe; I Nakashima; T Misu; I Miyazawa; Y Shiga; K Fujihara; Y Itoyama
Journal:  Mult Scler       Date:  2007-01       Impact factor: 6.312

5.  Patterns of antibody binding to aquaporin-4 isoforms in neuromyelitis optica.

Authors:  Simone Mader; Andreas Lutterotti; Franziska Di Pauli; Bettina Kuenz; Kathrin Schanda; Fahmy Aboul-Enein; Michael Khalil; Maria K Storch; Sven Jarius; Wolfgang Kristoferitsch; Thomas Berger; Markus Reindl
Journal:  PLoS One       Date:  2010-05-05       Impact factor: 3.240

6.  Devic's neuromyelitis optica treated with intravenous gamma globulin (IVIG).

Authors:  Jacqueline Bakker; Luanne Metz
Journal:  Can J Neurol Sci       Date:  2004-05       Impact factor: 2.104

7.  Devic's neuromyelitis optica: a clinicopathological study of 8 patients.

Authors:  R N Mandler; L E Davis; D R Jeffery; M Kornfeld
Journal:  Ann Neurol       Date:  1993-08       Impact factor: 10.422

8.  Intractable hiccup and nausea in neuromyelitis optica with anti-aquaporin-4 antibody: a herald of acute exacerbations.

Authors:  T Takahashi; I Miyazawa; T Misu; R Takano; I Nakashima; K Fujihara; M Tobita; Y Itoyama
Journal:  J Neurol Neurosurg Psychiatry       Date:  2008-04-17       Impact factor: 10.154

9.  Prevalence of neuromyelitis optica spectrum disorder and phenotype distribution.

Authors:  Elisa Bizzoco; Francesco Lolli; Anna Maria Repice; Bahia Hakiki; Mario Falcini; Alessandro Barilaro; Rosanna Taiuti; Gianfranco Siracusa; Maria Pia Amato; Tiziana Biagioli; Silvia Lori; Marco Moretti; Annalisa Vinattieri; Patrizia Nencini; Luca Massacesi; Sabrina Matà
Journal:  J Neurol       Date:  2009-05-28       Impact factor: 4.849

10.  Occurrence of acute large and edematous callosal lesions in neuromyelitis optica.

Authors:  M Nakamura; T Misu; K Fujihara; I Miyazawa; I Nakashima; T Takahashi; S Watanabe; Y Itoyama
Journal:  Mult Scler       Date:  2009-05-12       Impact factor: 6.312
View more
  15 in total

Review 1.  [Aquaporin 4 antibody-positive neuromyelitis optica spectrum disorders and myelin oligodendrocyte glycoprotein antibody-associated encephalomyelitis. A brief review].

Authors:  Sven Jarius; Brigitte Wildemann
Journal:  Nervenarzt       Date:  2021-03-31       Impact factor: 1.214

2.  [Therapeutic options for autoimmune encephalomyelitis].

Authors:  N Borisow; H Prüss; F Paul
Journal:  Nervenarzt       Date:  2013-04       Impact factor: 1.214

Review 3.  [Contribution of spinal cord biopsy to the differential diagnosis of longitudinal extensive transverse myelitis].

Authors:  M Ringelstein; O Aktas; J Harmel; D Prayer; S Jarius; B Wildemann; H-P Hartung; S Salhofer-Polanyi; F Leutmezer; P S Rommer
Journal:  Nervenarzt       Date:  2014-10       Impact factor: 1.214

4.  MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome.

Authors:  Sven Jarius; Klemens Ruprecht; Ingo Kleiter; Nadja Borisow; Nasrin Asgari; Kalliopi Pitarokoili; Florence Pache; Oliver Stich; Lena-Alexandra Beume; Martin W Hümmert; Marius Ringelstein; Corinna Trebst; Alexander Winkelmann; Alexander Schwarz; Mathias Buttmann; Hanna Zimmermann; Joseph Kuchling; Diego Franciotta; Marco Capobianco; Eberhard Siebert; Carsten Lukas; Mirjam Korporal-Kuhnke; Jürgen Haas; Kai Fechner; Alexander U Brandt; Kathrin Schanda; Orhan Aktas; Friedemann Paul; Markus Reindl; Brigitte Wildemann
Journal:  J Neuroinflammation       Date:  2016-09-27       Impact factor: 8.322

Review 5.  Longitudinal extensive transverse myelitis--it's not all neuromyelitis optica.

Authors:  Corinna Trebst; Peter Raab; Elke Verena Voss; Paulus Rommer; Mazen Abu-Mugheisib; Uwe K Zettl; Martin Stangel
Journal:  Nat Rev Neurol       Date:  2011-11-01       Impact factor: 42.937

Review 6.  [Ultrahigh field MRI in context of neurological diseases].

Authors:  J Kuchling; T Sinnecker; I Bozin; J Dörr; V I Madai; J Sobesky; T Niendorf; F Paul; J Wuerfel
Journal:  Nervenarzt       Date:  2014-04       Impact factor: 1.214

Review 7.  Present and Future Therapies in Neuromyelitis Optica Spectrum Disorders.

Authors:  Ingo Kleiter; Ralf Gold
Journal:  Neurotherapeutics       Date:  2016-01       Impact factor: 7.620

Review 8.  Neuromyelitis optica: clinical features, immunopathogenesis and treatment.

Authors:  S Jarius; B Wildemann; F Paul
Journal:  Clin Exp Immunol       Date:  2014-05       Impact factor: 4.330

9.  Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: A multicentre study of 175 patients.

Authors:  Sven Jarius; Klemens Ruprecht; Brigitte Wildemann; Tania Kuempfel; Marius Ringelstein; Christian Geis; Ingo Kleiter; Christoph Kleinschnitz; Achim Berthele; Johannes Brettschneider; Kerstin Hellwig; Bernhard Hemmer; Ralf A Linker; Florian Lauda; Christoph A Mayer; Hayrettin Tumani; Arthur Melms; Corinna Trebst; Martin Stangel; Martin Marziniak; Frank Hoffmann; Sven Schippling; Jürgen H Faiss; Oliver Neuhaus; Barbara Ettrich; Christian Zentner; Kersten Guthke; Ulrich Hofstadt-van Oy; Reinhard Reuss; Hannah Pellkofer; Ulf Ziemann; Peter Kern; Klaus P Wandinger; Florian Then Bergh; Tobias Boettcher; Stefan Langel; Martin Liebetrau; Paulus S Rommer; Sabine Niehaus; Christoph Münch; Alexander Winkelmann; Uwe K Zettl U; Imke Metz; Christian Veauthier; Jörn P Sieb; Christian Wilke; Hans P Hartung; Orhan Aktas; Friedemann Paul
Journal:  J Neuroinflammation       Date:  2012-01-19       Impact factor: 8.322

Review 10.  Challenges and opportunities in designing clinical trials for neuromyelitis optica.

Authors:  Brian G Weinshenker; Gerard Barron; Jacinta M Behne; Jeffery L Bennett; Peter S Chin; Bruce A C Cree; Jerome de Seze; Armando Flor; Kazuo Fujihara; Benjamin Greenberg; Sayumi Higashi; William Holt; Omar Khan; Volker Knappertz; Michael Levy; Angela T Melia; Jacqueline Palace; Terry J Smith; Maria Pia Sormani; Katja Van Herle; Susan VanMeter; Pablo Villoslada; Marc K Walton; Warren Wasiewski; Dean M Wingerchuk; Michael R Yeaman
Journal:  Neurology       Date:  2015-04-03       Impact factor: 9.910
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.